Related Experiment Videos
Targeting Malassezia species for Novel Synthetic and Natural Antidandruff Agents
Letizia Angiolella1, Simone Carradori2, Cristina Maccallini2
1Department of Public Health and Infectious Diseases, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy.
Abstract:
Malassezia spp. are lipophilic yeasts not only present in the normal skin microflora, but also responsible of skin-related diseases (pityriasis versicolor, seborrheic/atopic dermatitis and dandruff) as well as systemic fungal infections in humans and animals. Their treatment and eradication are mainly based on old azole drugs, which are characterized by poor compliance, unpredictable clinical efficacy, emerging resistance and several side effects. These drawbacks have prompted the research toward novel synthetic and natural derivatives/ nanomaterials targeting other pivotal enzymes/pathways such as carbonic anhydrase (MgCA) and lipases, alone or in combination, in order to improve the eradication rate of this fungus. This review accomplished an update on this important topic dealing with the latest discoveries of synthetic scaffolds and natural products for the treatment of Malassezia spp.-related diseases, thus suggesting new opportunities to design innovative and alternative anti-dandruff drugs.
Insights
New treatments for Malassezia yeasts, the cause of dandruff and other skin issues, are being explored. Research focuses on novel compounds targeting fungal enzymes to overcome limitations of current azole drugs.
Area of Science:
- Mycology
- Dermatology
- Medicinal Chemistry
Background:
- Malassezia species are lipophilic yeasts part of the skin's normal microflora.
- These yeasts are implicated in various skin conditions like pityriasis versicolor, seborrheic/atopic dermatitis, and dandruff.
- Current treatments rely on azole drugs, which suffer from poor compliance, variable efficacy, resistance, and side effects.
Purpose of the Study:
- To review recent advancements in synthetic and natural compounds for treating Malassezia-related diseases.
- To explore novel therapeutic targets beyond traditional azole pathways.
- To identify new opportunities for developing innovative anti-dandruff and anti-fungal agents.
Main Methods:
- Literature review of recent scientific discoveries.
- Analysis of synthetic scaffolds and natural products targeting Malassezia.
- Investigation of alternative pathways like carbonic anhydrase (MgCA) and lipases.
Main Results:
- Identification of novel synthetic derivatives and natural products with potential anti-Malassezia activity.
- Exploration of combination therapies targeting multiple fungal pathways.
- Highlighting the limitations of existing azole treatments necessitates alternative approaches.
Conclusions:
- Novel synthetic and natural agents show promise for treating Malassezia infections.
- Targeting enzymes like MgCA and lipases offers alternative strategies.
- This review provides insights for developing next-generation anti-dandruff and anti-fungal therapies.